Synopsis A clinical study demonstrates that use of sucrose octasulfate dressing improved rate of wound closure over 20 weeks in patients with neuroischaemic diabetic foot ulcers in comparison with use of a control dressing. This week's 'MED FACT' discusses a clinical trial from The Lancet Diabetes & Endocrinology , “ Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial ”. March, 2018.
Authors : Edmonds M; Lázaro-Martínez JL; Alfayate-García JM; Martini J; Petit JM; Rayman G; Lobmann R; Uccioli L; Sauvadet A; Bohbot S; Kerihuel JC. Key Takeaways Sucrose octasulfate dressings are an effective treatment for patients with neuroischaemic diabetic foot ulcers. Objective Study Type Participants To study the effect of sucrose octasulfate dressing versus a…
